End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.09 CNY | +0.05% | +0.10% | -13.74% |
Business Summary
Number of employees: 3,709
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Flu Vaccine
45.0
%
| 1,818 | 40.2 % | 2,403 | 45.0 % | +32.19% |
Human Serum Albumin
19.8
%
| 988 | 21.9 % | 1,057 | 19.8 % | +6.97% |
Other Blood Products
19.2
%
| 916 | 20.3 % | 1,025 | 19.2 % | +11.87% |
Intravenous C-ball
15.8
%
| 775 | 17.2 % | 845 | 15.8 % | +8.96% |
Other
0.2
%
| 20 | 0.4 % | 13 | 0.2 % | -36.17% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.7
%
| 4,499 | 99.6 % | 5,327 | 99.7 % | +18.40% |
Foreign
0.3
%
| 18 | 0.4 % | 15 | 0.3 % | -17.33% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bei Fan
CEO | Chief Executive Officer | 52 | 92-03-29 |
Jun Min Xie
DFI | Director of Finance/CFO | 56 | 10-09-30 |
Kang An
CHM | Chairman | 75 | 92-02-29 |
Xiao Wei Ma
CTO | Chief Tech/Sci/R&D Officer | 56 | 07-04-11 |
Wen Jue An
BRD | Director/Board Member | 35 | 15-05-31 |
Yan Chao Wang
BRD | Director/Board Member | 35 | 11-06-30 |
Wen Qi An
BRD | Director/Board Member | 45 | 09-06-30 |
Bao Xian Zhang
BRD | Director/Board Member | 53 | 08-03-25 |
Ruo Wen Pan
BRD | Director/Board Member | 56 | 93-01-31 |
Yuan Cheng Lou
IRC | Investor Relations Contact | 40 | 08-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kang An
CHM | Chairman | 75 | 92-02-29 |
Bei Fan
CEO | Chief Executive Officer | 52 | 92-03-29 |
Ruo Wen Pan
BRD | Director/Board Member | 56 | 93-01-31 |
Xiao Wei Ma
CTO | Chief Tech/Sci/R&D Officer | 56 | 07-04-11 |
Bao Xian Zhang
BRD | Director/Board Member | 53 | 08-03-25 |
Yun Long Wang
BRD | Director/Board Member | 62 | 20-04-14 |
Zhi Guo Su
BRD | Director/Board Member | 70 | - |
Wen Qi An
BRD | Director/Board Member | 45 | 09-06-30 |
Yan Chao Wang
BRD | Director/Board Member | 35 | 11-06-30 |
Wen Jue An
BRD | Director/Board Member | 35 | 15-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,833,195,126 | 952,293,137 ( 51.95 %) | 4,414,200 ( 0.2408 %) | 51.95 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.74% | 4.82B | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.94% | 29.36B | |
+53.11% | 24.49B | |
-5.41% | 17.31B | |
-44.23% | 11.26B | |
-17.60% | 11.62B | |
-13.96% | 11.31B | |
-0.22% | 8.31B |
- Stock Market
- Equities
- 002007 Stock
- Company Hualan Biological Engineering Inc.